This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Bostongene Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Anastasia Zotova: Innovator in Cancer Research
Introduction
Anastasia Zotova is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of cancer research, particularly in understanding tumor microenvironments. Her innovative work has the potential to impact cancer diagnosis and treatment.
Latest Patents
Anastasia holds a patent for her invention titled "Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration." This patent focuses on methods, systems, and computer-readable storage media that are useful for characterizing subjects with certain cancers, especially those typified by solid tumors. The disclosure outlines methods for determining a tumor microenvironment (TME) type of a cancer subject and assessing the subject's prognosis and likelihood of responding to various therapies based on the TME type determination. She has 1 patent to her name.
Career Highlights
Anastasia is currently employed at Bostongene Corporation, where she continues her research and development efforts in cancer diagnostics. Her work is instrumental in advancing the understanding of how immune escape mechanisms affect cancer progression and treatment responses.
Collaborations
Anastasia collaborates with talented professionals in her field, including Sofya Kust and Elena Ocheredko. These collaborations enhance her research and contribute to the collective knowledge in cancer studies.
Conclusion
Anastasia Zotova is a dedicated inventor whose work in cancer research is paving the way for innovative diagnostic and therapeutic approaches. Her contributions are vital to the ongoing fight against cancer, and her patent reflects her commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
